China’s Health Authorities Fighting Surge in Cases of Mpox, Comparison of Bivalent and Monovalent mRNA Vaccine Boosters, and Prediction of Cognitive Deficits 6 and 12 Months After COVID-19 Hospitalization Using Acute Blood Biomarker Profiles | VuMedi

MicrobeTV

China’s Health Authorities Fighting Surge in Cases of Mpox, Comparison of Bivalent and Monovalent mRNA Vaccine Boosters, and Prediction of Cognitive Deficits 6 and 12 Months After COVID-19 Hospitalization Using Acute Blood Biomarker Profiles

By MicrobeTV FEATURING Daniel Griffin, Vincent Racaniello

By MicrobeTV FEATURING Daniel Griffin, Vincent Racaniello

14 views

September 11, 2023

Comments 0

Login to view comments. Click here to Login